BioNexus Gene Lab (BGLC) FCF Payout Ratio (2023 - 2024)

BioNexus Gene Lab (BGLC) reported FCF Payout Ratio of 0.0 for Q3 2024, up 47.48% on a YoY basis from 0.0 in Q4 2023, and up 50.46% sequentially from 0.0 in Q2 2024.

BioNexus Gene Lab (BGLC) FCF Payout Ratio (2023 - 2024) Analysis & Trends

BioNexus Gene Lab (BGLC) has 2 years of FCF Payout Ratio data on file, last reported at 0.0 in Q3 2024.

  • For the quarter ending Q3 2024, FCF Payout Ratio rose 47.48% year-over-year to 0.0; the trailing twelve-month figure through Sep 2024 stood at 0.0 (changed N/A YoY), and the FY2023 full-year result was 0.0, down 102.32% from the prior year.
  • FCF Payout Ratio improved to 0.0 in Q3 2024, from 0.0 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 0.0 in Q3 2024 to a low of 0.05 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Linde 237.95 Bn 233.99 Bn 4.26 Bn 0.83
2 Sherwin Williams 78.17 Bn 77.95 Bn 2.78 Bn 246.38
3 Ecolab 76.02 Bn 75.37 Bn 1.85 Bn 0.25
4 Air Products & Chemicals 66.38 Bn 65.43 Bn 987.40 Mn 0.36
5 Ppg Industries 26.02 Bn 24.40 Bn 1.66 Bn -8.37
6 LyondellBasell Industries 22.51 Bn 19.87 Bn 701.00 Mn -0.42
7 Chemical & Mining Co Of Chile 19.70 Bn 15.83 Bn 778.60 Mn -
8 International Flavors & Fragrances 19.51 Bn 18.95 Bn 1.02 Bn 0.64
9 DuPont de Nemours 18.80 Bn 18.71 Bn 602.00 Mn 0.08
10 BioNexus Gene Lab 2.82 Mn -1.14 Mn -790.00 -

Historic Data

Download Data
DateValue
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 -0.05
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 -0.05
Mar 31, 2023 -0.01